CIK 0001326190 · Non-accelerated filer<br>Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 202726770
- Phone
- 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 4 Open-market buy Director bought 300 shares at $2.88 ($863)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Grant or award President and CEO acquired 126 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 1,825 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 691 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 568 shares (grant or award)
- 4 Grant or award Chief Business Officer acquired 1,832 shares (grant or award)
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale Director sold 2,714 shares at $15.00 ($40,710)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market buy Director bought 9,000 shares at $4.27 ($38,430)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 12 of 74 · 1,467 filings